Breaking News Instant updates and real-time market news.

PLX

Protalix

$5.14 /

+0.08 (+1.58%)

06:59
02/23/21
02/23
06:59
02/23/21
06:59

Protalix, Chiesi announces results from BRIGHT clinical trial of PRX-102

Protalix and Chiesi Global Rare Diseases announced topline results from the BRIGHT Phase III clinical trial evaluating pegunigalsidase alfa, or PRX-102, 2 mg/kg, administered every four weeks, for the potential treatment of Fabry disease. PRX-102 is the company's plant cell-expressed recombinant, PEGylated, cross-linked a-galactosidase-A product candidate. The BRIGHT study is a Phase III 12-month, open-label, switch-over study designed to evaluate the safety, efficacy and pharmacokinetics of PRX-102 treatment, 2 mg/kg every four weeks, in up to 30 patients with Fabry disease previously treated with a commercially available enzyme replacement therapy, or ERT, for at least three years and on a stable dose administered every two weeks. Topline results indicate that 2 mg/kg of PRX-102 administered by intravenous infusion every four weeks was found to be well tolerated among treated patients, and stable clinical presentation was maintained in adult Fabry patients. No new patients developed treatment-induced anti-drug antibodies, or ADA, following the switch to PRX-102 treatment. The BRIGHT study enrolled 30 adult patients. The most common Fabry disease symptoms were acroparesthesia, heat intolerance, angiokeratomas and hypohydrosis. All 30 patients received at least one dose of PRX-102, and 29 patients completed the 12-month study. Of these 29 patients, 28 received the intended regimen of 2 mg/kg every four weeks throughout the study, while one patient was switched to PRX-102 1 mg/kg every two weeks per protocol. One patient withdrew from the study after the first infusion due to a traffic accident. Following screening, patients were enrolled and switched from their then current ERT to intravenous, or IV, infusions of 2 mg/kg of PRX-102 every four weeks for 52 weeks. First infusions of PRX-102 were administered under controlled conditions at the investigation site. Based on the protocol-specified criteria, patients were able to receive their PRX-102 infusions at a home care setup once the Investigator and Sponsor Medical Monitor agreed that it was safe to do so. Safety and efficacy exploratory endpoints were assessed throughout the 52-week study. Study outcome measures showed plasma lyso-Gb3 concentrations remained stable during the study with a mean change of 3.01 nM from baseline to Week 52. Mean absolute change of eGFR values were stable during the 52-week treatment period, with a mean change from baseline of -1.27 mL/min/1.73 m2. Following a survey of participants using the Quality of Life EQ-5D-5L questionnaire, responses indicate that patient perception of their own health remained high and stable throughout the 52-week study duration, with overall health mean scores of 78.3 and 82.1 at baseline and Week 52, respectively, in a 0 to 100 scale. Using the short-form Brief Pain Inventory, or BPI, questionnaire, approximately 75% of study participants had an improvement or no change in average pain severity at Week 52. The short-form BPI interference items also remained stable during the study. Pain-related results indicate that there was no increase and/or relapse in pain. No Fabry clinical events were reported during the study. The company intends to report final data on the BRIGHT study in the second half of 2021, and to present these findings at an appropriate medical conference.

  • 12

    Feb

PLX Protalix
$5.14 /

+0.08 (+1.58%)

12/31/20 H.C. Wainwright
Protalix data underscore value proposition for PRX-102, says H.C. Wainwright

TODAY'S FREE FLY STORIES

Hot Stocks
GBS Inc. announces anticipated milestones » 08:47
05/14/21
05/14
08:47
05/14/21
08:47
GBS

GBS Inc.

$3.17 /

-0.28 (-8.12%)

Anticipated Events and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBS GBS Inc.
$3.17 /

-0.28 (-8.12%)

GBS GBS Inc.
$3.17 /

-0.28 (-8.12%)

Hot Stocks
CP says will respond to KCS in 'allotted time,' won't enter 'bidding war' » 08:47
05/14/21
05/14
08:47
05/14/21
08:47
CP

Canadian Pacific

$80.60 /

+2.216 (+2.83%)

, KSU

Kansas City Southern

$313.41 /

+7.14 (+2.33%)

, CNI

Canadian National

$111.04 /

+0.25 (+0.23%)

Last night, Canadian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$80.60 /

+2.216 (+2.83%)

KSU Kansas City Southern
$313.41 /

+7.14 (+2.33%)

CNI Canadian National
$111.04 /

+0.25 (+0.23%)

CP Canadian Pacific
$80.60 /

+2.216 (+2.83%)

06:12 Today Citi
Citi sees Canadian National, Kansas City Southern deal as most likely outcome
04/26/21 Deutsche Bank
Canadian Pacific price target raised to $405 from $368 at Deutsche Bank
04/26/21 Susquehanna
Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
04/23/21 Desjardins
Canadian Pacific price target raised to C$529 from C$525 at Desjardins
KSU Kansas City Southern
$313.41 /

+7.14 (+2.33%)

06:12 Today Citi
Citi sees Canadian National, Kansas City Southern deal as most likely outcome
04/26/21 Deutsche Bank
Kansas City Southern price target raised to $300 from $212 at Deutsche Bank
04/26/21 Susquehanna
Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
04/22/21 Credit Suisse
Canadian Pacific not planning to preemptively raise bid, says Credit Suisse
CNI Canadian National
$111.04 /

+0.25 (+0.23%)

06:12 Today Citi
Citi sees Canadian National, Kansas City Southern deal as most likely outcome
04/27/21 CIBC
Canadian National price target lowered to C$146 from C$148 at CIBC
04/27/21 Wells Fargo
Canadian National price target raised to $120 from $113 at Wells Fargo
04/26/21 Susquehanna
Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
CP Canadian Pacific
$80.60 /

+2.216 (+2.83%)

KSU Kansas City Southern
$313.41 /

+7.14 (+2.33%)

CNI Canadian National
$111.04 /

+0.25 (+0.23%)

CP Canadian Pacific
$80.60 /

+2.216 (+2.83%)

KSU Kansas City Southern
$313.41 /

+7.14 (+2.33%)

CNI Canadian National
$111.04 /

+0.25 (+0.23%)

CP Canadian Pacific
$80.60 /

+2.216 (+2.83%)

KSU Kansas City Southern
$313.41 /

+7.14 (+2.33%)

CNI Canadian National
$111.04 /

+0.25 (+0.23%)

KSU Kansas City Southern
$313.41 /

+7.14 (+2.33%)

Earnings
GBS Inc. reports Q1 EPS (27c) vs. (1c) last year » 08:46
05/14/21
05/14
08:46
05/14/21
08:46
GBS

GBS Inc.

$3.17 /

-0.28 (-8.12%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBS GBS Inc.
$3.17 /

-0.28 (-8.12%)

Hot Stocks
Evoke Pharma appoints Vickie Reed to board of directors » 08:45
05/14/21
05/14
08:45
05/14/21
08:45
EVOK

Evoke Pharma

$1.13 /

-0.4 (-26.14%)

, MRTX

Mirati Therapeutics

$154.90 /

+1.54 (+1.00%)

Evoke Pharma (EVOK)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVOK Evoke Pharma
$1.13 /

-0.4 (-26.14%)

MRTX Mirati Therapeutics
$154.90 /

+1.54 (+1.00%)

EVOK Evoke Pharma
$1.13 /

-0.4 (-26.14%)

06/22/20 H.C. Wainwright
Evoke Pharma upgraded to Buy from Neutral at H.C. Wainwright
MRTX Mirati Therapeutics
$154.90 /

+1.54 (+1.00%)

05/10/21 Jefferies
Jefferies upgrades Mirati Therapeutics to Buy after 35% pullback
05/10/21 Jefferies
Mirati Therapeutics upgraded to Buy from Hold at Jefferies
04/26/21 Credit Suisse
Mirati Therapeutics assumed with an Outperform at Credit Suisse
03/01/21 Oppenheimer
Mirati Therapeutics price target lowered to $255 from $260 at Oppenheimer
EVOK Evoke Pharma
$1.13 /

-0.4 (-26.14%)

MRTX Mirati Therapeutics
$154.90 /

+1.54 (+1.00%)

  • 14
    Jan
  • 28
    Oct
General news
U.S. April retail sales were unchanged, and declined -0.8% excluding autos » 08:45
05/14/21
05/14
08:45
05/14/21
08:45
$ECON

Economic Data

/

+

U.S. April retail sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Options
    Largest borrow rate increases among liquid names » 08:45
    05/14/21
    05/14
    08:45
    05/14/21
    08:45
    IPOE

    Social Capital Hedosophia Holdings Corp. V

    $14.71 /

    -0.32 (-2.13%)

    , UWMC

    UWM Holdings

    $7.42 /

    +0.05 (+0.68%)

    , QS

    QuantumScape

    $26.62 /

    -0.51 (-1.88%)

    , MNMD

    MindMed

    $3.00 /

    +0.07 (+2.39%)

    , NMM

    Navios Maritime Partners

    $28.91 /

    +0.62 (+2.19%)

    , CLMT

    Calumet Specialty Products

    $5.49 /

    -0.04 (-0.72%)

    , ATOS

    Atossa Therapeutics

    $2.37 /

    -0.095 (-3.86%)

    , SAND

    Sandstorm Gold

    $8.06 /

    -0.02 (-0.25%)

    , BLNK

    Blink Charging

    $26.18 /

    -2.64 (-9.16%)

    , BGS

    B&G Foods

    $29.27 /

    +0.575 (+2.00%)

    Latest data shows the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IPOE Social Capital Hedosophia Holdings Corp. V
    $14.71 /

    -0.32 (-2.13%)

    UWMC UWM Holdings
    $7.42 /

    +0.05 (+0.68%)

    QS QuantumScape
    $26.62 /

    -0.51 (-1.88%)

    MNMD MindMed
    $3.00 /

    +0.07 (+2.39%)

    NMM Navios Maritime Partners
    $28.91 /

    +0.62 (+2.19%)

    CLMT Calumet Specialty Products
    $5.49 /

    -0.04 (-0.72%)

    ATOS Atossa Therapeutics
    $2.37 /

    -0.095 (-3.86%)

    SAND Sandstorm Gold
    $8.06 /

    -0.02 (-0.25%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    BGS B&G Foods
    $29.27 /

    +0.575 (+2.00%)

    IPOE Social Capital Hedosophia Holdings Corp. V
    $14.71 /

    -0.32 (-2.13%)

    03/17/21 Wedbush
    LendingClub price target raised to $20.50 from $14 at Wedbush
    UWMC UWM Holdings
    $7.42 /

    +0.05 (+0.68%)

    04/21/21 Barclays
    UWM Holdings initiated with an Overweight at Barclays
    03/26/21 Credit Suisse
    Credit Suisse lowers estimates on mortgage originators
    02/23/21 Credit Suisse
    UWM Holdings initiated with an Outperform at Credit Suisse
    02/17/21 Goldman Sachs
    UWM Holdings initiated with a Neutral at Goldman Sachs
    QS QuantumScape
    $26.62 /

    -0.51 (-1.88%)

    03/08/21 Cowen
    Cowen bullish on battery technology, starts QuantumScape at Outperform
    03/08/21 Cowen
    QuantumScape initiated with an Outperform at Cowen
    03/04/21 Baird
    QuantumScape initiated with a Neutral at Baird
    02/11/21 Morgan Stanley
    QuantumScape initiated with an Overweight at Morgan Stanley
    MNMD MindMed
    $3.00 /

    +0.07 (+2.39%)

    NMM Navios Maritime Partners
    $28.91 /

    +0.62 (+2.19%)

    02/24/21 Citi
    Navios Maritime Partners price target raised to $21 from $7.50 at Citi
    01/29/21 Janney Montgomery Scott
    Navios Maritime Partners price target raised to $20 from $15 at Janney Montgomery Scott
    01/08/21 Jefferies
    Navios Maritime Partners upgraded to Buy, price target doubled at Jefferies
    01/08/21 Jefferies
    Navios Maritime Partners upgraded to Buy from Hold at Jefferies
    CLMT Calumet Specialty Products
    $5.49 /

    -0.04 (-0.72%)

    03/24/21 Wells Fargo
    Calumet Specialty Products upgraded to Overweight at Wells Fargo
    03/24/21 Wells Fargo
    Calumet Specialty upgraded to Overweight from Equal Weight at Wells Fargo
    12/15/20 Wells Fargo
    Calumet Specialty Products downgraded to Equal Weight at Wells Fargo
    12/15/20 Wells Fargo
    Calumet Specialty downgraded to Equal Weight from Overweight at Wells Fargo
    ATOS Atossa Therapeutics
    $2.37 /

    -0.095 (-3.86%)

    09/17/20 Ascendiant
    Ascendiant starts Atossa Therapeutics with Buy rating, $7 price target
    09/17/20 Ascendiant
    Atossa Therapeutics initiated with a Buy at Ascendiant
    07/17/20 Maxim
    Atossa Therapeutics price target raised to $8 from $4 at Maxim
    07/16/20 Maxim
    Maxim doubles Atossa price target to $8 on positive COVID data
    SAND Sandstorm Gold
    $8.06 /

    -0.02 (-0.25%)

    02/12/21 National Bank
    Sandstorm Gold price target lowered to C$13.50 from C$14.25 at National Bank
    02/08/21 CIBC
    Sandstorm Gold price target lowered to C$13.50 from C$16.75 at CIBC
    01/11/21 National Bank
    Sandstorm Gold price target lowered to C$14.25 from C$15.50 at National Bank
    12/16/20 Roth Capital
    Sandstorm Gold initiated with a Buy at Roth Capital
    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    05/11/21
    Fly Intel: Top five analyst initiations
    05/11/21 Needham
    Blink Charging initiated with a Buy at Needham
    05/10/21 Needham
    Blink Charging initiated with a Buy at Needham
    03/08/21 Cowen
    Blink Charging initiated with an Outperform at Cowen
    BGS B&G Foods
    $29.27 /

    +0.575 (+2.00%)

    03/22/21
    Fly Intel: Top five analyst downgrades
    03/22/21 Piper Sandler
    B&G Foods downgraded to Neutral from Overweight at Piper Sandler
    03/03/21 RBC Capital
    B&G Foods price target lowered to $29 from $32 at RBC Capital
    01/19/21 Stephens
    B&G Foods initiated with an Equal Weight at Stephens
    QS QuantumScape
    $26.62 /

    -0.51 (-1.88%)

    NMM Navios Maritime Partners
    $28.91 /

    +0.62 (+2.19%)

    CLMT Calumet Specialty Products
    $5.49 /

    -0.04 (-0.72%)

    SAND Sandstorm Gold
    $8.06 /

    -0.02 (-0.25%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    BGS B&G Foods
    $29.27 /

    +0.575 (+2.00%)

    • 25
      Mar
    • 08
      Jan
    IPOE Social Capital Hedosophia Holdings Corp. V
    $14.71 /

    -0.32 (-2.13%)

    QS QuantumScape
    $26.62 /

    -0.51 (-1.88%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    IPOE Social Capital Hedosophia Holdings Corp. V
    $14.71 /

    -0.32 (-2.13%)

    QS QuantumScape
    $26.62 /

    -0.51 (-1.88%)

    CLMT Calumet Specialty Products
    $5.49 /

    -0.04 (-0.72%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    BGS B&G Foods
    $29.27 /

    +0.575 (+2.00%)

    IPOE Social Capital Hedosophia Holdings Corp. V
    $14.71 /

    -0.32 (-2.13%)

    UWMC UWM Holdings
    $7.42 /

    +0.05 (+0.68%)

    QS QuantumScape
    $26.62 /

    -0.51 (-1.88%)

    MNMD MindMed
    $3.00 /

    +0.07 (+2.39%)

    NMM Navios Maritime Partners
    $28.91 /

    +0.62 (+2.19%)

    CLMT Calumet Specialty Products
    $5.49 /

    -0.04 (-0.72%)

    ATOS Atossa Therapeutics
    $2.37 /

    -0.095 (-3.86%)

    SAND Sandstorm Gold
    $8.06 /

    -0.02 (-0.25%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    BGS B&G Foods
    $29.27 /

    +0.575 (+2.00%)

    Hot Stocks
    Ultragenyx announces longer-term data from OTC phase 1/2, HeLa PCL studies » 08:44
    05/14/21
    05/14
    08:44
    05/14/21
    08:44
    RARE

    Ultragenyx

    $106.65 /

    +0.06 (+0.06%)

    Ultragenyx Pharmaceutical…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    RARE Ultragenyx
    $106.65 /

    +0.06 (+0.06%)

    RARE Ultragenyx
    $106.65 /

    +0.06 (+0.06%)

    05/06/21
    Fly Intel: Top five analyst upgrades
    05/06/21 Citi
    Ultragenyx upgraded to Buy from Neutral at Citi
    05/05/21 Evercore ISI
    Evercore upgrades Ultragenyx with 'good handle' on Angelman program
    05/05/21 Evercore ISI
    Ultragenyx upgraded to Outperform from In Line at Evercore ISI
    RARE Ultragenyx
    $106.65 /

    +0.06 (+0.06%)

    • 29
      Oct
    Hot Stocks
    Ultragenyx announces longer-term data from Glycogen Storage Disease study » 08:43
    05/14/21
    05/14
    08:43
    05/14/21
    08:43
    RARE

    Ultragenyx

    $106.65 /

    +0.06 (+0.06%)

    Ultragenyx Pharmaceutical…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    RARE Ultragenyx
    $106.65 /

    +0.06 (+0.06%)

    RARE Ultragenyx
    $106.65 /

    +0.06 (+0.06%)

    05/06/21
    Fly Intel: Top five analyst upgrades
    05/06/21 Citi
    Ultragenyx upgraded to Buy from Neutral at Citi
    05/05/21 Evercore ISI
    Evercore upgrades Ultragenyx with 'good handle' on Angelman program
    05/05/21 Evercore ISI
    Ultragenyx upgraded to Outperform from In Line at Evercore ISI
    RARE Ultragenyx
    $106.65 /

    +0.06 (+0.06%)

    • 29
      Oct
    Hot Stocks
    Assure Holdings sees 17,000 total procedures for 2021 » 08:43
    05/14/21
    05/14
    08:43
    05/14/21
    08:43
    ARHH

    Assure Holdings

    $1.17 /

    -0.015 (-1.27%)

    The Company forecasts…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ARHH Assure Holdings
    $1.17 /

    -0.015 (-1.27%)

    ARHH Assure Holdings
    $1.17 /

    -0.015 (-1.27%)

    Earnings
    Assure Holdings reports Q1 EPS (2c) vs. (1c) last year » 08:43
    05/14/21
    05/14
    08:43
    05/14/21
    08:43
    ARHH

    Assure Holdings

    $1.17 /

    -0.015 (-1.27%)

    Reports Q1 revenue $4.8M…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ARHH Assure Holdings
    $1.17 /

    -0.015 (-1.27%)

    ARHH Assure Holdings
    $1.17 /

    -0.015 (-1.27%)

    Recommendations
    Airbnb remains 'the best asset in travel,' says Jefferies » 08:42
    05/14/21
    05/14
    08:42
    05/14/21
    08:42
    ABNB

    Airbnb

    $135.95 /

    -4.22 (-3.01%)

    Jefferies analyst Brent…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    08:16 Today Evercore ISI
    Airbnb price target lowered to $195 from $245 at Evercore ISI
    08:02 Today Truist
    Airbnb price target lowered to $160 from $180 at Truist
    07:45 Today Morgan Stanley
    Airbnb gaining share at accelerating pace, says Morgan Stanley
    07:35 Today BofA
    Airbnb 'growing into valuation,' says BofA
    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    • 10
      Dec
    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    Hot Stocks
    AYR Wellness launches Revel flower in Pennsylvania » 08:41
    05/14/21
    05/14
    08:41
    05/14/21
    08:41
    AYRWF

    AYR Strategies

    $26.65 /

    -1.23 (-4.41%)

    Ayr Wellness announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    AYRWF AYR Strategies
    $26.65 /

    -1.23 (-4.41%)

    AYRWF AYR Strategies
    $26.65 /

    -1.23 (-4.41%)

    03/12/21 Canaccord
    AYR Strategies price target raised to C$70 from C$60 at Canaccord
    01/06/21 Northland
    AYR Strategies named a top pick, price target boosted to $35 at Northland
    12/24/20 Cantor Fitzgerald
    AYR Strategies price target raised to $24.50 from $24 at Cantor Fitzgerald
    12/11/20 Canaccord
    AYR Strategies price target raised to C$45 from C$40 at Canaccord
    General news
    April retail sales control group down 1.5% vs. last month, consensus 0.1%  08:40
    05/14/21
    05/14
    08:40
    05/14/21
    08:40
    $ECON

    Economic Data

    /

    +

     
    ShowHide Related Items >><<
      Hot Stocks
      FDA opens public comment period on Philip Morris IQOS 3 MTRP application » 08:40
      05/14/21
      05/14
      08:40
      05/14/21
      08:40
      PM

      Philip Morris

      $97.55 /

      +1.37 (+1.42%)

      The FDA opened a public…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      PM Philip Morris
      $97.55 /

      +1.37 (+1.42%)

      PM Philip Morris
      $97.55 /

      +1.37 (+1.42%)

      05/06/21 Morgan Stanley
      Philip Morris price target raised to $110 from $105 at Morgan Stanley
      04/22/21 Barclays
      Philip Morris price target raised to $110 from $103 at Barclays
      04/21/21 Morgan Stanley
      Philip Morris positioned for above-algorithm EPS growth, says Morgan Stanley
      04/20/21 Citi
      Biden bill would be 'severe blow' to tobacco, says Citi
      PM Philip Morris
      $97.55 /

      +1.37 (+1.42%)

      PM Philip Morris
      $97.55 /

      +1.37 (+1.42%)

      PM Philip Morris
      $97.55 /

      +1.37 (+1.42%)

      PM Philip Morris
      $97.55 /

      +1.37 (+1.42%)

      Hot Stocks
      Verano Holdings announces filing of preliminary base shelf prospectus » 08:39
      05/14/21
      05/14
      08:39
      05/14/21
      08:39
      VRNOF

      Verano Holdings

      $19.74 /

      +0.24 (+1.23%)

      Verano Holdings announced…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      VRNOF Verano Holdings
      $19.74 /

      +0.24 (+1.23%)

      VRNOF Verano Holdings
      $19.74 /

      +0.24 (+1.23%)

      03/12/21 Canaccord
      Verano Holdings initiated with a Speculative Buy at Canaccord
      VRNOF Verano Holdings
      $19.74 /

      +0.24 (+1.23%)

      VRNOF Verano Holdings
      $19.74 /

      +0.24 (+1.23%)

      Initiation
      AFC Gamma initiated with a Buy at Lake Street » 08:38
      05/14/21
      05/14
      08:38
      05/14/21
      08:38
      AFCG

      AFC Gamma

      /

      +

      Lake Street analyst Mark…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      AFCG AFC Gamma
      /

      +

      AFCG AFC Gamma
      /

      +

      04/13/21 Seaport Global
      Seaport Global starts cannabis lender AFC Gamma at Buy
      04/13/21 JMP Securities
      AFC Gamma initiated with an Outperform at JMP Securities
      04/13/21 Seaport Global
      AFC Gamma initiated with a Buy at Seaport Global
      04/12/21 Ladenburg
      AFC Gamma initiated with Neutral on valuation at Ladenburg
      AFCG AFC Gamma
      /

      +

      • 19
        Mar
      AFCG AFC Gamma
      /

      +

      Recommendations
      Chicken Soup for the Soul price target raised to $54 from $48 at Craig-Hallum » 08:38
      05/14/21
      05/14
      08:38
      05/14/21
      08:38
      CSSE

      Chicken Soup for the Soul

      $32.89 /

      -1.855 (-5.34%)

      Craig-Hallum analyst…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      CSSE Chicken Soup for the Soul
      $32.89 /

      -1.855 (-5.34%)

      CSSE Chicken Soup for the Soul
      $32.89 /

      -1.855 (-5.34%)

      07:06 Today Alliance Global Partners
      Chicken Soup for the Soul price target raised to $52 at Alliance Global
      05/13/21 Canaccord
      Canaccord starts Chicken Soup for the Soul with Buy, $50 price target
      05/13/21 Canaccord
      Chicken Soup for the Soul initiated with a Buy at Canaccord
      04/12/21 Craig-Hallum
      Chicken Soup for the Soul price target raised to $48 from $35 at Craig-Hallum
      Hot Stocks
      Simply Good Foods to restate financial statements for 2020, 2019, 2018 » 08:37
      05/14/21
      05/14
      08:37
      05/14/21
      08:37
      SMPL

      Simply Good Foods

      $33.18 /

      +0.56 (+1.72%)

      The Simply Good Foods…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      SMPL Simply Good Foods
      $33.18 /

      +0.56 (+1.72%)

      SMPL Simply Good Foods
      $33.18 /

      +0.56 (+1.72%)

      04/06/21 Credit Suisse
      Simply Good Foods initiated with a Neutral at Credit Suisse
      03/19/21 Jefferies
      Simply Good Foods downgraded to Hold on valuation at Jefferies
      03/19/21 Jefferies
      Simply Good Foods downgraded to Hold from Buy at Jefferies
      02/03/21 DA Davidson
      Simply Good Foods downgraded to Neutral from Buy at DA Davidson
      SMPL Simply Good Foods
      $33.18 /

      +0.56 (+1.72%)

      SMPL Simply Good Foods
      $33.18 /

      +0.56 (+1.72%)

      Recommendations
      Electronic Arts price target raised to $150 from $143 at BMO Capital » 08:37
      05/14/21
      05/14
      08:37
      05/14/21
      08:37
      EA

      Electronic Arts

      $139.03 /

      -0.65 (-0.47%)

      BMO Capital analyst…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      EA Electronic Arts
      $139.03 /

      -0.65 (-0.47%)

      EA Electronic Arts
      $139.03 /

      -0.65 (-0.47%)

      05/12/21 Benchmark
      Electronic Arts price target raised to $181 from $177 at Benchmark
      05/12/21 Barclays
      Electronic Arts price target lowered to $142 from $145 at Barclays
      05/10/21 Credit Suisse
      Electronic Arts price target raised to $167 from $160 at Credit Suisse
      04/22/21 Jefferies
      Jefferies upgrades Electronic Arts to Buy, sees sentiment as 'too negative'
      EA Electronic Arts
      $139.03 /

      -0.65 (-0.47%)

      EA Electronic Arts
      $139.03 /

      -0.65 (-0.47%)

      EA Electronic Arts
      $139.03 /

      -0.65 (-0.47%)

      EA Electronic Arts
      $139.03 /

      -0.65 (-0.47%)

      Hot Stocks
      Misonix appoints Patrick Beyer to board of directors » 08:36
      05/14/21
      05/14
      08:36
      05/14/21
      08:36
      MSON

      Misonix

      $18.58 /

      +0.22 (+1.20%)

      , CNMD

      Conmed

      $140.84 /

      +3.53 (+2.57%)

      Misonix (MSON) announced…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      MSON Misonix
      $18.58 /

      +0.22 (+1.20%)

      CNMD Conmed
      $140.84 /

      +3.53 (+2.57%)

      MSON Misonix
      $18.58 /

      +0.22 (+1.20%)

      07/13/20 Craig-Hallum
      Misonix price target raised to $23 from $18 at Craig-Hallum
      CNMD Conmed
      $140.84 /

      +3.53 (+2.57%)

      04/29/21 Piper Sandler
      Conmed price target raised to $160 from $145 at Piper Sandler
      01/28/21 Piper Sandler
      Conmed price target raised to $145 from $95 at Piper Sandler
      09/30/20 Piper Sandler
      Piper Sandler 'highly' recommends five names in Medical Technology
      07/29/20 Piper Sandler
      Conmed price target raised to $95 from $90 at Piper Sandler
      MSON Misonix
      $18.58 /

      +0.22 (+1.20%)

      CNMD Conmed
      $140.84 /

      +3.53 (+2.57%)

      MSON Misonix
      $18.58 /

      +0.22 (+1.20%)

      Recommendations
      Haemonetics price target lowered to $85 from $105 at Jefferies » 08:35
      05/14/21
      05/14
      08:35
      05/14/21
      08:35
      HAE

      Haemonetics

      $51.81 /

      -8.035 (-13.43%)

      Jefferies analyst Anthony…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      HAE Haemonetics
      $51.81 /

      -8.035 (-13.43%)

      HAE Haemonetics
      $51.81 /

      -8.035 (-13.43%)

      08:23 Today Barrington
      Haemonetics price target lowered to $71 from $91 at Barrington
      06:29 Today JMP Securities
      Haemonetics price target lowered to $90 from $110 at JMP Securities
      04/20/21 Raymond James
      CSL's Haemonetics contract end due to Terumo agreement, says Raymond James
      04/20/21 Jefferies
      Jefferies says 'premature' to permanently exclude CSL as Haemonetics customer
      HAE Haemonetics
      $51.81 /

      -8.035 (-13.43%)

      HAE Haemonetics
      $51.81 /

      -8.035 (-13.43%)

      Hot Stocks
      Betway announces multiyear partnership with the National Hockey League » 08:35
      05/14/21
      05/14
      08:35
      05/14/21
      08:35
      SEAH

      Sports Entertainment Acquisition

      $9.99 /

      -0.115 (-1.14%)

      SGHC Limited, which…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      SEAH Sports Entertainment Acquisition
      $9.99 /

      -0.115 (-1.14%)

      SEAH Sports Entertainment Acquisition
      $9.99 /

      -0.115 (-1.14%)

      SEAH Sports Entertainment Acquisition
      $9.99 /

      -0.115 (-1.14%)

      General news
      April retail sales ex-vehicles and gas down 0.8% vs. last month, consensus 0.7%  08:35
      05/14/21
      05/14
      08:35
      05/14/21
      08:35
      $ECON

      Economic Data

      /

      +

       
      ShowHide Related Items >><<
        General news
        April retail sales ex-vehicles down 0.8% vs. last month, consensus 0.8%  08:35
        05/14/21
        05/14
        08:35
        05/14/21
        08:35
        $ECON

        Economic Data

        /

        +

         
        ShowHide Related Items >><<
          General news
          April retail sales up 0.0% vs. last month, consensus 1.0%  08:35
          05/14/21
          05/14
          08:35
          05/14/21
          08:35
          $ECON

          Economic Data

          /

          +

           
          ShowHide Related Items >><<

            Get Full Fly Access

            Breaking market intelligence sent straight to you
            Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
            Up-to-date information on important industry events
            Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
            News focused on the companies in your portfolio
            Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.